Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07240038Recruiting

Reduction of the Incidence of NAV in Neonatal Units (INBERNAV-Neo)

Role: collaborator

NCT04435470Completed

Epidemiological Study of the Microbiota in Critically Ill Children

Role: collaborator

NCT01881490Not ApplicableCompleted

The ImageKids Study: Developing the pMEDIC and the PICMI

Role: collaborator

NCT01951040Completed

Effect of Synthetic Oxytocin Administered During Labor on Breastfeedings

Role: lead

All 4 trials loaded